IVIG Privigen denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for ivig privigen are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Step Therapy for Privigen — and Why You Can Appeal

Privigen (immune globulin intravenous, 10%) is used for serious immune-mediated and neurological conditions, yet UnitedHealthcare's coverage policy for IVIG may require documented trials of alternative therapies before approving Privigen. Step-therapy requirements are designed to ensure cost-effective prescribing but can delay access to clinically appropriate treatment. When the required prior steps are medically inappropriate, have already been completed, or when your condition warrants direct access to Privigen, the step-therapy requirement is appealable.

## Why This Denial Is Appealable

Step-therapy protocols must account for individual clinical circumstances. UHC's policy — and many state step-therapy reform laws — require granting exceptions when a required prior therapy is clinically contraindicated, was previously tried and failed, or when requiring the step-therapy sequence would cause clinically significant delay or harm. Even on purely federal ERISA grounds, the full-and-fair review standard means UHC must weigh your individual medical record rather than enforce a blanket protocol.

## Federal Appeal Framework

• ERISA §503 (employer plans): Guarantees access to UHC's step-therapy criteria and a meaningful review of your clinical circumstances.
• ACA §2719 / State external review: After internal levels are exhausted, an independent reviewer — not employed by UHC — evaluates whether the step-therapy denial was clinically appropriate. Step-therapy denials have a strong record at external review when documentation is complete. Act within approximately four months of your denial notice.
• Expedited review: If your condition is deteriorating or if delayed access to Privigen poses a serious health risk, request expedited review at every level.

## Your Appeal Process

1. Obtain the denial letter and UHC's step-therapy criteria for IVIG/Privigen. 2. Identify each required prior step and document your history with each — tried and failed, clinically contraindicated, or otherwise inapplicable. 3. File a Level 1 internal appeal with a complete documentation package within the deadline on your denial notice. 4. If denied internally, proceed to Level 2 (if available) and then to external review.

## Documentation to Gather

• Diagnosis confirmation: Specialist notes, diagnostic workup, and objective test results establishing your condition and its severity.
• Prior-treatment history: For each therapy UHC's policy requires, include dates of trial, dosing duration, and documented clinical outcomes — failure, inadequate response, or intolerance with supporting chart notes.
• Clinical-exception basis: If a required prior therapy was never tried because it is medically inappropriate for your case, your prescriber must document this clearly with clinical reasoning.
• Disease progression or urgency records: Evidence that delaying Privigen while completing additional step-therapy steps would cause clinically significant harm.
• Medical-necessity letter: A detailed, individualized letter from your specialist explaining your diagnosis, treatment history, and why Privigen is the appropriate next step — referencing the applicable guideline organization (e.g., relevant neurology or immunology society guidance) generically.

## Criteria-Mapping Strategy

Obtain UHC's published step-therapy policy for Privigen/IVIG. List every required step and document point-by-point how each has been satisfied, attempted, or clinically precluded. A table — required step on the left, your evidence on the right — is the clearest format for the reviewer. If your state has enacted step-therapy exception legislation, name it in your appeal letter and cite the specific exception grounds that apply to your case.